Evolv Technologies Holdings, Inc.

NasdaqCM:EVLV 株式レポート

時価総額：US$893.0m

Evolv Technologies Holdings 将来の成長

Future 基準チェック /16

Evolv Technologies Holdingsの収益は年間35.5%で減少すると予測されていますが、年間収益は年間17.4%で増加すると予想されています。EPS は年間34.1%で減少すると予想されています。

主要情報

-35.5%

収益成長率

-34.13%

EPS成長率

Electronic 収益成長26.2%
収益成長率17.4%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日08 Sep 2026

今後の成長に関する最新情報

Recent updates

ナラティブ更新 • Sep 08

EVLV: 2026 Manufacturing Ramp And New Contracts Will Drive Upside

Analysts have trimmed their fair value estimate for Evolv Technologies Holdings from $10.00 to $8.00. This aligns it with a new $8.00 price target that reflects updated assumptions for revenue growth, profit margins and future P/E expectations following recent research coverage.
分析記事 • Jun 21

Evolv Technologies Holdings (EVLV) Stock Could Be 43.5% Undervalued After DHS SAFETY Act Designation

Evolv Technologies Holdings (EVLV) is back in focus after the US Department of Homeland Security granted SAFETY Act Designation to its Evolv eXpedite bag screening system, placing both core products on the Qualified Anti-Terrorism Technologies list. See our latest analysis for Evolv Technologies Holdings. Even with the SAFETY Act news drawing fresh attention, Evolv Technologies Holdings’ share price has been under pressure in 2026, with the year to date share price return down 15.67% and the...
ナラティブ更新 • Jun 16

EVLV: SAFETY Act Wins And 2026 Manufacturing Ramp Will Drive Upside

Analysts have maintained their consolidated price target for Evolv Technologies Holdings at $10.50, citing recent Q1 results, clarification of misreported data, and commentary on revenue trends, margins, and longer term manufacturing benefits as key supports for this level. Analyst Commentary on Evolv Technologies Holdings Recent research coverage on Evolv Technologies Holdings centers on the Q1 report, the clarification of misreported information via an 8-K filing, and updated views on revenue growth, margins, and longer term manufacturing plans.
ナラティブ更新 • Jun 02

EVLV: 2026 Contract Manufacturing Ramp Will Drive Long Term Upside

Analysts have nudged their average price target on Evolv Technologies Holdings higher from $9.50 to $10.00, pointing to what they see as strong Q1 execution, improved RPO growth, and the potential for 2026 to mark a positive inflection in growth and profitability, despite recent share price dislocation linked to reporting confusion. Analyst Commentary Recent research highlights a generally constructive stance on Evolv Technologies Holdings after Q1, with several firms pointing to what they see as strong execution, raised guidance, and improving contract metrics such as remaining performance obligations.
ナラティブ更新 • May 02

EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside

Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
ナラティブ更新 • Apr 18

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
ナラティブ更新 • Apr 03

EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside

Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.
ナラティブ更新 • Mar 20

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
ナラティブ更新 • Mar 06

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).
ナラティブ更新 • Feb 20

EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026

Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.
ナラティブ更新 • Feb 05

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.
ナラティブ更新 • Jan 22

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.
ナラティブ更新 • Jan 08

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.
ナラティブ更新 • Dec 14

EVLV: ARR Momentum Will Drive A Breakout Year In 2026

Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.
ナラティブ更新 • Aug 16

Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.
User avatar
新しいナラティブ • Jun 01

AI Screening Will Expand Public Safety Applications

Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.
分析記事 • May 21

The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%

Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...

業績と収益の成長予測

NasdaqCM:EVLV - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2028274-13N/A641
12/31/2027219-378425
12/31/2026182-362245
6/30/2026171-5-628N/A
3/31/2026160-36-1018N/A
12/31/2025146-33-1819N/A
9/30/2025137-60-356N/A
6/30/2025121-88-256N/A
3/31/2025114-44-47-17N/A
12/31/2024104-54-68-31N/A
9/30/202495-55-85-37N/A
6/30/202489-21-101-39N/A
3/31/202483-91-102-23N/A
12/31/202380-108-82-10N/A
9/30/202377-120-71-12N/A
6/30/202376-142-77-31N/A
3/31/202365-101-80-49N/A
12/31/202253-87-99-75N/A
9/30/202241-53-110-84N/A
6/30/202233-14-113-91N/A
3/31/202228-11-97-74N/A
12/31/202123-11-74-57N/A
9/30/202119-25-61-47N/A
6/30/202112-52-41-28N/A
3/31/20218-35-36-27N/A
12/31/20205-27-30-23N/A
12/31/20196-20N/A-15N/A

アナリストによる今後の成長予測

収入対貯蓄率: EVLV今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: EVLV今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: EVLV今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: EVLVの収益 ( 17.4% ) US市場 ( 13.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: EVLVの収益 ( 17.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: EVLVの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/09/10 06:07
終値2026/09/10 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Evolv Technologies Holdings, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5

アナリスト機関
Jeremy HamblinCraig-Hallum Capital Group LLC
Eric MartinuzziLake Street Capital Markets, LLC
Michael LatimoreNorthland Capital Markets